Pulmonx Corp Stock Investor Sentiment

LUNG Stock  USD 8.68  0.24  2.69%   
Roughly 70% of Pulmonx Corp's investor base is looking to short. The analysis of overall sentiment of trading Pulmonx Corp stock suggests that many investors are alarmed at this time. The current market sentiment, together with Pulmonx Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use Pulmonx Corp stock news signals to limit their universe of possible portfolio assets.
  

Pulmonx Corp Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Pulmonx Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
few days ago at simplywall.st         
Pulmonx Corporation Just Reported Full-Year Earnings Have Analysts Changed Their Mind On The Stock?
Simply Wall St News at Macroaxis
few days ago at finance.yahoo.com         
Pulmonx Full Year 2024 Earnings Beats Expectations
Yahoo News
few days ago at seekingalpha.com         
Pulmonx projects 16-18 percent constant currency growth for 2025 with key initiatives scaling
seekingalpha News
few days ago at benzinga.com         
Disposition of 12417 shares by Glendon French of Pulmonx Corp at 8.76 subject to Rule 16b-3
benzinga news
few days ago at insidermonkey.com         
Pulmonx Corporation Q4 2024 Earnings Call Transcript
insidermonkey News
few days ago at finance.yahoo.com         
Pulmonx Corp Q4 2024 Earnings Call Highlights Strong Revenue Growth Amid Financial ...
Yahoo News
few days ago at gurufocus.com         
Pulmonx Corp Q4 2024 Earnings Call Highlights Strong Revenue Growth Amid Financial ...
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Q4 2024 Pulmonx Corp Earnings Call Transcript
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
What To Expect From Pulmonx Corp Q4 2024 Earnings
Yahoo News
few days ago at seekingalpha.com         
Pulmonx GAAP EPS of -0.33 beats by 0.11, revenue of 23.8M beats by 1.51M
seekingalpha News
few days ago at gurufocus.com         
What To Expect From Pulmonx Corp Q4 2024 Earnings
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Pulmonx Corp Q4 2024 Earnings EPS Loss of 0. ...
Gurufocus Stories at Macroaxis
over a week ago at zacks.com         
Phreesia Moves 5.6 percent Higher Will This Strength Last?
zacks News
over a week ago at gurufocus.com         
Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
Pulmonx Co. Receives Consensus Rating of Moderate Buy from Analysts
news
Far too much social signal, news, headlines, and media speculation about Pulmonx Corp that are available to investors today. That information is available publicly through Pulmonx media outlets and privately through word of mouth or via Pulmonx internal channels. However, regardless of the origin, that massive amount of Pulmonx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pulmonx Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pulmonx Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pulmonx Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pulmonx Corp alpha.

Pulmonx Corp Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Insider Selling Pulmonx Co. Director Sells 20,000 Shares of Stock
11/27/2024
2
Disposition of 1184 shares by Geoffrey Rose of Pulmonx Corp at 10.6 subject to Rule 16b-3
12/05/2024
3
Acquisition by Geoffrey Rose of 69100 shares of Pulmonx Corp at 9.3 subject to Rule 16b-3
12/23/2024
4
Disposition of 2221 shares by Glendon French of Pulmonx Corp at 6.5 subject to Rule 16b-3
01/17/2025
5
Glendon E. French III Sells 2,326 Shares of Pulmonx Co. Stock
01/23/2025
6
Morgan Stanley Reduces Stake in Pulmonx Corp by 21.74
02/04/2025
7
Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day
02/13/2025
8
Phreesia Moves 5.6 percent Higher Will This Strength Last
02/14/2025
9
What To Expect From Pulmonx Corp Q4 2024 Earnings
02/19/2025
10
Q4 2024 Pulmonx Corp Earnings Call Transcript
02/20/2025
11
Pulmonx Full Year 2024 Earnings Beats Expectations
02/21/2025

Complementary Tools for Pulmonx Stock analysis

When running Pulmonx Corp's price analysis, check to measure Pulmonx Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmonx Corp is operating at the current time. Most of Pulmonx Corp's value examination focuses on studying past and present price action to predict the probability of Pulmonx Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmonx Corp's price. Additionally, you may evaluate how the addition of Pulmonx Corp to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios